Baidu
map

第一届吉林省创伤骨科高峰论坛 暨吉林省医学会骨科专业委员会创伤学组成立大会召开

2015-02-04 佚名 骨科在线

由吉林省医学会主办,吉林大学中日联谊医院承办的第一届吉林省创伤骨科高峰论坛今日在长春召开。本次会议不仅是一场高层次、高水平的学术盛宴,也是一场分享学术成果的盛宴;会议邀请了国内众多创伤大腕专家,就临床中的经验、体会及最新的学术成果进行深入的探讨、交流,吸引了千余名骨科同仁前来参加。 会议伊始举办了吉林省医学会骨科专业委员会创伤学组成立仪式。吉林大学中日联谊医院刘光耀主任当选为学组组长,吉

由吉林省医学会主办,吉林大学中日联谊医院承办的第一届吉林省创伤骨科高峰论坛今日在长春召开。本次会议不仅是一场高层次、高水平的学术盛宴,也是一场分享学术成果的盛宴;会议邀请了国内众多创伤大腕专家,就临床中的经验、体会及最新的学术成果进行深入的探讨、交流,吸引了千余名骨科同仁前来参加。

会议伊始举办了吉林省医学会骨科专业委员会创伤学组成立仪式。吉林大学中日联谊医院刘光耀主任当选为学组组长,吉林大学第一医院孙大辉主任、吉林大学第二医院吴丹凯主任、吉林省中医院齐万里主任担任学组副组长。刘光耀组长做了简短发言,今后将带领学组持续开展学术活动,加强学术交流;此外由于学组委员涵盖了长春地区、四平地区、通化地区及延吉等地区,学术活动还可延伸到基层,提高基层水平,促进吉林省创伤骨科的整体发展。

刘光耀组长主持开幕式

随后,第一届吉林省创伤骨科高峰论坛开幕。吉林省医学会骨科学分会创伤学组组长、吉林大学中日联谊医院刘光耀主任主持开幕式。

吉林省医学会秘书长琴钢首先代表吉林省医学会对此次会议的召开表示祝贺,对前来参会的专家、代表表示欢迎。随着医学的不断发展,各学科的专业发展尤为重要,创伤学组的成立为我省骨科学的发展画上了浓重一笔,使我省向骨科专业化发展迈进了重要一步;此次会议的召开,必将推动我省骨科事业的发展和整体水平的提升。

琴钢秘书长致辞

大会主席、吉林省医学会骨科专业委员会主任委员高忠礼教授具体介绍了会议盛情邀请的各大腕专家:中华医学会骨科学分会候任主任委员张英泽教授,中华医学会骨科学分会创伤学组名誉组长王满宜教授,中华医学会骨科学分会创伤学组组长唐佩福教授,中华医学会骨科学分会创伤学组秘书汤欣教授,中华医学会骨科学分会创伤学组副组长张长青教授、刘璠教授、吴新宝教授,哈尔滨医科大学附属第一医院毕郑刚教授,中国医科大学附属盛京医院杨军教授等;高教授希望利用这一平台,各位专家能够充分交流经验,分享信息,各位参会代表虚心听课,踊跃发言,学以致用。

大会主席高忠礼教授致辞

吉林大学中日联谊医院院长赵国庆教授介绍到中日联谊医院骨科成立于1949年,迄今已有60年的发展历史,现有床位308张,是吉林省卫生厅、吉林大学、中日联谊医院四级重点学科;中日联谊医院创伤骨科是吉林省创伤的摇篮和培训基地,是吉林省创伤骨科的治疗中心。近年来,医院的创伤骨科发展迅速,如今吉林省医学会骨科专业委员会创伤学组的成立更为我院创伤骨科的发展带来了新的启迪与动力,为我省创伤骨科的发展注入了新的活力。

赵国庆院长致辞

中华医学会骨科学分会候任主任委员张英泽教授、中华医学会骨科学分会创伤学组组长唐佩福教授也分别代表中华医学会骨科学分会及中华医学会骨科学分会创伤学组对此次会议的召开及吉林省医学会骨科专业委员会创伤学组的成立表示祝贺,将支持该学组今后的学术活动,促进吉林省创伤事业的发展。

张英泽教授致辞

唐佩福教授致辞

伴随着各位专家代表对会议召开、创伤学组成立的祝贺,一场高层次、高水平的学术盛宴正式开始。上午主要为省外专家就各自的专业领域进行专题报告,涉及肩肘、股骨、胫骨、足踝、髋臼等方面,王满宜教授、唐佩福教授、张英泽教授、张长青教授、吴新宝教授分别就前臂骨折、骨科大手术后VTE预防、隐匿血管损伤、股骨颈骨折及髋臼骨折进行了专题演讲,刘璠教授、汤欣教授则带来了胫骨近端骨折与足踝外科的最新进展;下午主要为吉林省内专家就髋臼、股骨、肱骨等的骨折进行经验的分享交流。

王满宜教授授课

紧张充实的学术盛宴持续了一天,此次会议的召开必将对吉林省创伤骨科事业的发展起到积极的推动作用。

会议现场


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=46767, encodeId=99f846e6737, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Dec 19 22:37:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662853, encodeId=4052166285366, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon Jun 22 08:19:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20903, encodeId=8513209033e, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:45:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15406, encodeId=f034154068a, content=大牛云集。, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Sat Feb 14 16:06:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335071, encodeId=9d5213350e14d, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Fri Feb 06 04:19:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
    2015-12-19 老段

    恭喜

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=46767, encodeId=99f846e6737, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Dec 19 22:37:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662853, encodeId=4052166285366, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon Jun 22 08:19:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20903, encodeId=8513209033e, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:45:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15406, encodeId=f034154068a, content=大牛云集。, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Sat Feb 14 16:06:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335071, encodeId=9d5213350e14d, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Fri Feb 06 04:19:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=46767, encodeId=99f846e6737, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Dec 19 22:37:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662853, encodeId=4052166285366, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon Jun 22 08:19:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20903, encodeId=8513209033e, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:45:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15406, encodeId=f034154068a, content=大牛云集。, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Sat Feb 14 16:06:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335071, encodeId=9d5213350e14d, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Fri Feb 06 04:19:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
    2015-04-12 x35042875

    患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=46767, encodeId=99f846e6737, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Dec 19 22:37:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662853, encodeId=4052166285366, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon Jun 22 08:19:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20903, encodeId=8513209033e, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:45:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15406, encodeId=f034154068a, content=大牛云集。, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Sat Feb 14 16:06:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335071, encodeId=9d5213350e14d, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Fri Feb 06 04:19:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]
    2015-02-14 chinayinhan

    大牛云集。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=46767, encodeId=99f846e6737, content=恭喜, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Dec 19 22:37:00 CST 2015, time=2015-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662853, encodeId=4052166285366, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Mon Jun 22 08:19:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20903, encodeId=8513209033e, content=患OS这个疾病的高风险人群提供干预措施以避免不良预后和机械治疗措施, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sun Apr 12 07:45:00 CST 2015, time=2015-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15406, encodeId=f034154068a, content=大牛云集。, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da6b7222, createdName=chinayinhan, createdTime=Sat Feb 14 16:06:00 CST 2015, time=2015-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335071, encodeId=9d5213350e14d, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Fri Feb 06 04:19:00 CST 2015, time=2015-02-06, status=1, ipAttribution=)]

相关资讯

“血栓”危害超乎想象

血栓形成,即血凝块形成,可以阻塞动脉或静脉血流,可以发生在任何年龄、任何时间。血栓形成是全球前三位的致死性心血管病——心脏病、脑卒中和静脉血栓栓塞症(VTE)的共同发病机制。 一般来说,长期卧床、肢体制动、大手术或创伤后、晚期肿瘤或有明显VTE家族史等均是VTE的危险因素。如果出现下肢的突然疼痛、肿胀、活动后加重;有的可见小腿浅静脉的扩张或显露,严重者可伴有体温升高、心率加快,皮肤苍白甚至呈青紫

骨科大手术围手术期管理――VTE预防

11月20~23日,中华医学会第十六届骨科学术会议暨第九届中国骨科学会(COA)国际学术大会在北京国家会议中心隆重召开。作为我国骨科学界年度最大的盛会,本届COA年会为与会者带来了这一领域所取得的最新研究成果及临床应用进展,极大地促进了领域内专家学者的交流与分享。在会议期间的一场卫星会上,上海长征医院吴海山教授就骨科大手术围术期管理的静脉血栓栓塞症(VTE)预防部分进行了报告,以期能给临床

全剂量利伐沙班治疗老年与慢性肾病VTE是安全的

临床实践中,为了减少出血风险,慢性肾脏病患者利伐沙班的剂量都下调整至最小,其中体弱者或80岁以上老年人的剂量也有下调整。但是最新的实验研究显示,在治疗深静脉血栓和肺栓塞时,1种剂量的利伐沙班适用所有。在美国血液学会最近一次的会议上,来自荷兰的Harry Buller博士对EINSTEIN DVT试验和EINSTEIN肺栓塞试验中利伐沙班的安全性和疗效进行了汇总分析。一共对约8200名患者进行了分析

AJOG:顺产要不要预防静脉血栓栓塞?

在产科,除了“羊水栓塞”近来被广为人知以外,还有一个栓塞值得一提,那就是静脉血栓栓塞(VTE),别看它名字笼统,威力可不小。 WHO研究显示,在发达国家有14.9%的孕产妇死亡由血栓栓塞相关疾病导致,其中肺栓塞占9.4%。栓塞病势凶猛,预后不佳,预防显得尤为重要。 英国指南建议对有血栓倾向(获得性或遗传性易栓症)或既往栓塞史,肥胖、年龄>35岁、吸烟、子痫前期、产后出血、产程

BMJ:遗传性血栓形成倾向的诊断和治疗

本文要点 遗传性血栓形成倾向的患病率约为5%,可增加静脉血栓栓塞症(VTE)的风险,但大部分患者不会出现深静脉血栓形成和肺栓塞。 遗传性血栓形成倾向的诊断并不会影响静脉血栓栓塞症的急性期治疗,并且很少影响到VTE的长期治疗。 遗传性血栓形成倾向的检测应告知患者相关的检测结果为何会改变治疗,未得到患者的同意不应对深静脉血栓形成和肺栓塞患者提供检测。 由于VTE的家族史

Baidu
map
Baidu
map
Baidu
map